Aditxt, Inc. (NASDAQ:ADTX) Sees Significant Decrease in Short Interest

Aditxt, Inc. (NASDAQ:ADTX) was the target of a significant drop in short interest in August. As of August 31st, there was short interest totalling 25,700 shares, a drop of 96.2% from the August 15th total of 672,800 shares. Approximately 0.7% of the shares of the stock are sold short. Based on an average trading volume of 2,430,000 shares, the short-interest ratio is currently 0.0 days.

Aditxt Trading Up 2.5 %

NASDAQ ADTX opened at $0.50 on Friday. Aditxt has a 12 month low of $0.42 and a 12 month high of $27.82. The company’s 50 day simple moving average is $1.11 and its 200 day simple moving average is $2.01.

Aditxt (NASDAQ:ADTX) last issued its quarterly earnings results on Monday, August 19th. The company reported ($4.19) earnings per share (EPS) for the quarter. Aditxt had a negative net margin of 5,016.31% and a negative return on equity of 615.43%. The firm had revenue of $0.04 million for the quarter.

Aditxt Company Profile

Aditxt, Inc, a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.